UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2003
Business Overview: The Company operates acute care hospitals, behavioral health care facilities, and international acute care hospitals (primarily in France). Operations are segmented into Acute Care Hospital Services, Behavioral Health Services, International Acute Care Hospital Services, and Other (centralized services and outpatient centers).

Key Financial Metrics

Note: Operating Income is defined by management as Net Revenues less salaries, wages & benefits, other operating expenses, supplies expense, and provision for doubtful accounts. It excludes depreciation, amortization, lease/rental, and interest expenses.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 12% year-over-year for both the quarter and the six-month period. Growth was driven by a 9% increase in same-facility revenues, $19 million in revenue from facilities acquired in Q1 2003 (France and U.S.), and $9 million in other increases (including $5 million from French GAAP to U.S. GAAP reclassifications).
• Profitability: Operating income increased 16% for the quarter and 15% for the six-month period. Operating margins improved to 16.7% (Q2) and 16.7% (YTD) from 16.0% and 16.2% in the prior year, respectively. This improvement was primarily due to decreased pharmacy costs from a new outsourcing agreement.
• Net Income: Net income rose 15% for the quarter and 15% for the six-month period. Increases were offset by higher depreciation and interest expenses related to the new George Washington University Hospital and recent acquisitions.
• Cash Flow: Operating cash flow for the six months ended June 30, 2003, increased significantly to $210.2 million from $134.1 million in the prior year, aided by a $43 million favorable change in accounts receivable.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Capital Expenditures: The Company spent $98.4 million on capital expenditures in the first six months of 2003. It expects to spend an additional $100 million to $125 million in the remainder of the year, totaling approximately $200 million to $225 million for 2003. Projects include a new hospital in Las Vegas and expansions in Texas and Florida.
• Acquisitions: The Company entered into an agreement to purchase three acute care hospitals in California for approximately $120 million, subject to regulatory and bankruptcy approvals, with a target closing by the end of 2003.
• Reimbursement Trends: Management anticipates continued pressure on operating margins due to Medicare payment reductions (BBA-97) and the shift toward managed care, which typically pays lower rates than traditional indemnity insurers. However, the Company secured price increases from many commercial payors.

Risks and Contingencies

• Insurance Liability: Due to unfavorable insurance markets, the Company is self-insured for malpractice up to $25 million per occurrence. Total accruals for professional and general liability claims (including PHICO-related claims) were $169.4 million as of June 30, 2003. There is uncertainty regarding ultimate liability if claims exceed reserves.
• Government Reimbursement: A significant portion of revenue (approx. 41% for the quarter) comes from Medicare and Medicaid. Changes in federal or state budgets, reimbursement rates, or audit adjustments could materially impact results. Specific risks include potential overpayments in Texas DSH programs and changes in outlier payment methodologies.
• HIPAA Compliance: The Company is implementing HIPAA regulations. Failure to comply or resolve implementation issues could result in fines or operational disruptions.

Investor Verification Checklist

• Self-Insurance Reserves: Verify the adequacy of the $169.4 million liability reserve, particularly regarding PHICO liquidation claims and potential state guaranty fund recoveries.
• California Acquisition: Monitor the status of the $120 million acquisition of three California hospitals, noting the contingencies related to bankruptcy and regulatory approvals.
• Medicaid Exposure: Assess the impact of potential Texas Medicaid DSH overpayment investigations and the expiration of DSH programs in Texas and South Carolina.
• Capital Spending: Confirm the Company's ability to fund the projected $200-$225 million in capital expenditures using internal cash flow and existing credit facilities ($341 million unused capacity).
• GAAP Reclassifications: Review the impact of the $5 million (quarter) and $11 million (six-month) revenue reclassifications related to French operations to ensure accurate year-over-year comparisons.